AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Paliperidone in South Africa

9 products registered with SAHPRA — 7 active

Brand / ProductReg. No.HolderStatusExpires
INVEGA 12 mg42/2.6.5/0287Janssen Pharmaceutica (Pty) Ltdsuspended7 Dec 2022
INVEGA 9 mg42/2.6.5/0286Janssen Pharmaceutica (Pty) Ltdsuspended11 Nov 2022
XEPLION 150 mg/1,50 ml44/2.6.5/0870Janssen Pharmaceutica (Pty) Ltdactive1 Jan 1900
INVEGA 6 mg42/2.6.5/0285Janssen Pharmaceutica (Pty) Ltdactive1 Jan 1900
XEPLION 75 mg/0,75 ml44/2.6.5/0867Janssen Pharmaceutica (Pty) Ltdactive1 Jan 1900
XEPLION 25 mg/0,25 ml44/2.6.5/0865Janssen Pharmaceutica (Pty) Ltdactive1 Jan 1900
INVEGA 3 mg42/2.6.5/0284Janssen Pharmaceutica (Pty) Ltdactive1 Jan 1900
XEPLION 50 mg/0,50 ml44/2.6.5/0866Janssen Pharmaceutica (Pty) Ltdactive1 Jan 1900
XEPLION 100 mg/1,0 ml44/2.6.5/0868Janssen Pharmaceutica (Pty) Ltdactive1 Jan 1900

Paliperidone — SAHPRA Registration Details

SAHPRA (South Africa) has 9 registered products containing Paliperidone, of which 7 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Paliperidone registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.